Sanaria Inc.
Rockville, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 9610 Medical Center Dr #200, Rockville, MD 20850, USA
- Website
- sanaria.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$26,505 |
| FY2023 | $89,055 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Seattle Children's Hospital | R01AI172824 | $92,600 | |
| Emory University | UM1AI148684 | $81,916 | |
| The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | HU00012520035 | $300,419 | |
| University Of Maryland, Baltimore | R34AI179569 | $40,500 | |
| Seattle Children's Hospital | R01AI172824 | $557,549 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| L2 Diagnostics LLC | Woodbridge, CT | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Biological Mimetics, Inc. | Frederick, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Abvacc, Inc. | Rockville, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| National Lutheran Health And Medical Board | Chennai, TN | — |
| L S T M | England | 611310 Colleges, Universities, and Professional Schools |
About the company
Sanaria Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of malaria vaccines and related biological research. The company focuses on creating innovative solutions for malaria prevention, particularly through the development of Plasmodium falciparum sporozoite (PfSPZ) vaccines. As a for-profit, veteran-owned business registered in SAM.gov, Sanaria Inc. provides specialized biological research services, vaccine development, and scientific research products to federal agencies, with a primary emphasis on malaria-related scientific advancements.
Through federal contract awards, Sanaria Inc. has primarily worked with agencies like the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Advancing Translational Sciences (NCATS). The company has secured several purchase order contracts for specialized biological services, including the provision of PfSPZ reagent biological kits, asexual malaria blood culture services, and research-oriented biological materials. These contracts have ranged in value from $43,467 to $89,054, typically involving the delivery of specific biological products and services supporting medical research. The contracts were awarded on a non-set-aside basis, demonstrating the company's unique capabilities in providing specialized malaria-related biological research materials.
Sanaria Inc. has been awarded multiple federal grants, predominantly from the National Institute of Allergy and Infectious Diseases, focusing on advanced malaria vaccine research and development. The grant awards support various critical research initiatives, including modularizing PfSPZ vaccine manufacture, developing conditional male lethal Anopheles stephensi lines, and creating genetically modified sporozoite vaccines. These grants range from Small Business Innovation Research (SBIR) program phases to cooperative agreements, with award values between $43,000 and $298,596. The research aims to improve malaria vaccine efficacy, develop more efficient manufacturing processes, and explore innovative approaches to malaria prevention. The company has also engaged in sub-grant collaborations with institutions like the University of Maryland, Baltimore, and Seattle Children's Hospital, expanding its research network and scientific impact.
Quick answers
Is Sanaria Inc. registered in SAM.gov?
Yes. Sanaria Inc.'s SAM.gov registration is active through September 10, 2027.
What is Sanaria Inc.'s CAGE code?
Sanaria Inc.'s CAGE code is 30DP1, and its Unique Entity ID (UEI) is YLF2SS2NYGC5.
How much has Sanaria Inc. received in federal contracts?
Federal contracts obligated $62,550 to Sanaria Inc. in fiscal years 2023 through 2027.
What is Sanaria Inc.'s most recent federal award?
Sanaria Inc.'s most recent federal contract award is Pfspz reagents biological kits (ambis #2228227) (75N93024P00793), from National Institute of Allergy and Infectious Diseases (NIH), on June 28, 2024.
On GovTribe
See Sanaria Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors